Limited-stage Small Cell Lung Cancer (LS-SCLC) research hub

Phase 3 Study of Toripalimab Alone or in Combination With Tifcemalimab as Consolidation Therapy in Patients With Limited-stage Small Cell Lung Cancer (LS-SCLC)

This study is looking at new treatments for a type of lung cancer called limited-stage small cell lung cancer. It tests two new drugs, toripalimab and tifcemalimab, alone or together, after standard chemotherapy and radiation, to see if they can help stop the cancer from coming back.